{
    "nctId": "NCT01850147",
    "officialTitle": "Study of Efficacy and Safety of Sequential Low-dose Sunitinib With Chemotherapy in Advanced Non-small Cell Lung Cancer After Failure of Conventional Regimen",
    "inclusionCriteria": "* Histologic or cytologic diagnosis of stage IIIB/IV NSCLC\n* ECOG PS: 0,1\n* Unidimensional or bi-dimensional measurable disease\n* Receive prior treatment including first-line platinum-based chemotherapy, standard second-line chemotherapy and 1 EGF/EGFR inhibitor\n* Evidence of disease progression\n* Life expectancy \\>12 weeks\n* Neutrophils \\> 1.5 109/l, Platelets \\> 100 109/l, Hemoglobin \\> 9g/dl, Total bilirubin \\< 1.5 UNL, AST (SGOT) and ALT (SGPT) \\< 2.5 UNL, Alkaline phosphatases \\< 5 UNL, Creatinine \\< 1 UNL\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Pre-existing hemoptysis of a severity \\> grade 3 by NCI CTCAE criteria within 4 weeks prior to study entry\n* Uncontrolled hypertension\n* CHF, angina or arrhythmias\n* LVEF \\< 1 UNL\n* Existing a second malignancy within 5 years\n* Infected with HIV"
}